The pathway in one paragraph
Cells build NAD+ from precursors. NR is converted to NMN, and NMN is converted to NAD+. Supplying a precursor asks the cell to finish the job; supplying NAD+ provides the finished molecule but faces an absorption problem.
Why oral NAD+ underdelivers
NAD+ is large and polar and is substantially degraded in the gut. That is the practical reason precursors dominate the supplement shelf while NAD+ itself is given by injection or intranasally.
What the human evidence looks like
Precursor trials in humans have shown they can raise measurable NAD levels, with clinical outcome findings that remain early and mixed. Injectable NAD+ has less human outcome data than the precursors, not more. Research is ongoing.
NAD+ is a coenzyme required by every cell to convert nutrients into usable energy.
How to think about choosing
This is a conversation about goals, tolerability, cost and route preference with a clinician, not a ranking. A precursor capsule and a prescribed injection are different commitments in every sense.
What none of them are
None is FDA-approved as a compounded preparation, none is proven to extend lifespan in humans, and none replaces sleep, training or nutrition. See the 30-second film answers for this medication.
What NAD+ actually does inside a cell
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every cell you have. Its job is electron transfer: it accepts electrons during the breakdown of food and carries them to the mitochondria, where that energy is converted into ATP. It is also a required substrate for sirtuins and PARP enzymes, which participate in DNA repair and in regulating gene expression. Tissue NAD+ levels decline with age in human and animal studies, and that observation is what motivated interest in supplementation. What has not been established is that raising measured NAD+ produces any specific clinical outcome in humans. That gap between mechanism and outcome is the honest state of the field, and it is why do NAD+ injections work is written as a discussion of evidence quality rather than a promise.
Compounded medications are not FDA-approved.
Why the route of administration matters so much here
NAD+ is a large, charged molecule, and that single fact explains most of the product landscape. Taken orally as NAD+ itself, the majority is broken down in the gut before absorption, which is why oral products usually supply precursors such as NMN or NR instead, or wrap the molecule in a lipid carrier. Injection bypasses digestion entirely and delivers the molecule to circulation, which is why it is the most direct route. Intranasal preparations use the thin, richly vascular nasal lining as a middle path with no needle. Nasal versus injection and NAD+ versus NMN versus NR compare these directly. Bioavailability data for compounded preparations specifically is limited, and no route has been shown to be clinically superior for a particular outcome.
The flush, and why it happens
Many people report a warm, flushed, occasionally prickly sensation during or shortly after NAD+ administration, sometimes with a feeling of chest pressure or a need to slow the infusion. This is a recognised and generally transient effect associated with rate of delivery: slower administration is commonly reported to reduce it. It is not evidence that the preparation is working, and it is not evidence that something is wrong. What it does mean is that administration instructions from your dispensing pharmacy matter, particularly the rate. Anything beyond a brief flush, and specifically chest pain, difficulty breathing, or a reaction that does not settle, is a reason to stop and contact a clinician. Compounded NAD+ preparations are not FDA-approved and FDA does not review them for safety, effectiveness, or quality before marketing.
Frequency, dosing, and who decides
There is no FDA-approved dosing schedule for compounded NAD+, because there is no FDA-approved NAD+ drug product for these uses. Schedules in practice are set by the prescribing clinician and the dispensing pharmacy, and they vary. What that means practically is that a schedule you read about online is someone else’s prescription, not a benchmark for yours. Ask your clinician what schedule they are prescribing and why, what they would consider a reason to change it, and how long they intend to continue before reassessing. Follow the instructions supplied with your specific preparation. How often NAD+ injections are given goes into the range you will see described and why the range is wide rather than settled.
Answer a few questions. A licensed clinician decides what, if anything, is appropriate.
Frequently asked questions
Is NMN better than NR?
Human comparative outcome data are limited and do not support a confident ranking. Both are precursors that raise NAD availability.
Why would I inject NAD+ instead of taking a precursor?
Route and absorption. Your clinician weighs that against cost, convenience and your goals.
Do NAD+ injections work?
NAD+ has a well-characterised role in cellular energy metabolism and DNA repair, and tissue levels decline with age. What has not been established is that raising NAD+ produces a specific clinical outcome in humans. Compounded preparations are not FDA-approved.
Are NAD+ injections safe?
Short-term tolerability is generally described as acceptable, with flushing and injection-site reactions most commonly reported. Long-term safety data in healthy adults is limited, and compounded preparations are not evaluated by FDA before marketing. A clinician decides whether it is appropriate for you.
How often should you take NAD+ injections?
There is no FDA-approved schedule, because there is no approved NAD+ drug product for these uses. Your prescribing clinician sets the frequency and reassesses it. Schedules described online are other people’s prescriptions.
Where do you inject NAD+?
Follow the route and site instructions supplied with your preparation. Subcutaneous administration is common for at-home preparations, with site rotation. Rate of administration matters because it relates to the flushing sensation.
Cut through the marketing with a clinician
Ask what fits your goals rather than what ranks best online. Rx only.
Rx only. A licensed clinician decides whether treatment is appropriate and may determine that no treatment, or a different treatment, is right for you. Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality before marketing. Individual results vary.
Sources
Clinical trials listed below evaluated FDA-approved products at the doses studied. They are cited as published science, not as evidence about any compounded preparation, which is not FDA-approved and has not been evaluated by FDA for safety, effectiveness, or quality.
- Peer-reviewedCovarrubias AJ et al. NAD+ metabolism and its roles in cellular processes during ageing. Nat Rev Mol Cell Biol 2021;22:119-141
- ReferenceCleveland Clinic: NAD (nicotinamide adenine dinucleotide)
- NIHNIH Office of Dietary Supplements: Niacin (NAD+ precursors)
- FDA guidanceFDA: Compounding and the FD&C Act, Section 503A
Spotted something inaccurate? Report an error – corrections are logged per our editorial standards.
More on NAD+
Same medication, different question.
